Submitted by jkegerize on
ACLA Comment: Orders/Laboratory Order for Draft USCDI Version 6
The American Clinical Laboratory Association (ACLA) appreciates the opportunity to comment on the data element, Laboratory Orders.
ACLA is writing to express support and specific feedback for the overall changes made to the United States Core Data for Interoperability (USCDI) version 6, specifically the establishment of the LOINC lab standard for laboratory orders and broadening the use of the Unique Device Identifier (UDI). ACLA believes improvements to interoperability should focus on the high-quality treatment of patients and we believe that the USCDI will help drive interoperability forward. Efforts ensuring that laboratory orders contain the necessary information for timely and high-quality treatment of a patient is critical to our national interoperability infrastructure.
The adoption of the LOINC lab standard for laboratory orders in USCDI version 6 brings numerous benefits to the healthcare industry. The change promotes standardization and harmonization of laboratory order data with the existing Laboratory data classification is the right choice. While LOINC adoptions have challenges, the selection of LOINC 2.78 as the Laboratory Order standard gives providers the opportunity to align the Laboratory Order data elements with the existing Laboratory Tests data class, which has used LOINC as the standard since USCDI v1.
While we support the changes to the data foundations there are several challenges that may hamper the broad adoption of LOINC as a standard. The speed for new tests to receive a LOINC code continues to be an issue, which can take between 12-18 months to be finalized. This process creates a major issue with making new cutting-edge tests available to patients and providers. Without faster code assignment, there will be slower adoption. Further, legacy interfaces and LIS systems may not currently support the use of LOINC for orders and the costs of improvements are significant. Finally, there are challenges with the use of LOINC for reflex orders.
We commend the U.S. Department of Health and Human Services for recognizing the importance of the LOINC lab standard and incorporating it into USCDI version 6. This change demonstrates a commitment to advancing healthcare interoperability and improving patient care. Given that LOINC for laboratories are currently not supported by most laboratories and would have an impact on the technology and operational aspects, we suggest that ASTP work with the FDA, CMS/CLIA, public health agencies, laboratories, and instrument manufacturers to establish a practical roadmap. We believe that the adoption of the USCDI will have a positive and lasting impact on the healthcare industry, fostering innovation and driving improvements in healthcare delivery.







Submitted by jkegerize on
ACLA Comment on USDCI v6: Laboratory Order
The American Clinical Laboratory Association (ACLA) appreciates the opportunity to comment on the data element, Laboratory Order.
The LOINC version 2.81 (most recent release) includes new LOINC order level codes that have been aligned to SNOMED. These terms have made it significantly easier to assign order level LOINC. ACLA recommends the selection of LOINC 2.81 instead of LOINC 2.80.
While we support the changes to the data foundations there are several challenges that may hamper the broad adoption of LOINC as a standard. The speed for new tests to receive a LOINC code continues to be an issue, which can take between 12-18 months to be finalized. This process creates a major issue with making new cutting-edge tests available to patients and providers. Without faster code assignment, there will be slower adoption. Further, legacy interfaces and LIS systems may not currently support the use of LOINC for orders and the costs of improvements are significant. Finally, there are challenges with the use of LOINC for reflex orders.